查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466636

眼科市場：按疾病、產品類型、最終用戶分類 - 全球預測 2024-2030

Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses & Lens), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年眼科市場規模為599億美元，預計2024年將達638.9億美元，複合年成長率為6.64%，2030年將達939.9億美元。

眼科學包括對眼科疾病的診斷和治療的藥物和手術的研究。近年來，在白內障手術、屈光矯正手術和青光眼手術中觀察到眼科領域的許多重要發展。設備齊全的醫療基礎設施和藥品核准的增加對市場做出了巨大貢獻。另一方面，眼科疾病率的上升和全球人口意識的提高正在推動市場的成長。此外，由於技術進步導致眼保健設備價格上漲和眼保健成本上升可能會限制市場成長。眼科治療方法領域的新興研發活動得到巨額投資的支持，使得市場蓬勃發展。此外，持續的技術進步和人工智慧的整合用於眼科疾病的早期檢測創造了利潤豐厚的市場機會。

主要市場統計
基準年[2023] 599億美元
預測年份 [2024] 638.9億美元
預測年份 [2030] 939.9億美元
複合年成長率（%） 6.64%

疾病：與老齡化的黃斑部病變疾病增加，導致中央視力進行性喪失

老齡化黃斑部病變(AMD) 是最常見的疾病，主要影響老年人並導致中央視力進行性喪失。此疾病分為乾性（非新生血管）和濕性（新生血管）類型。乾型的特徵是黃斑區有玻璃膜疣堆積，而濕型則伴隨新生血管，導致視力迅速喪失。危險因子包括年齡、遺傳、吸菸和生活方式。抗 VEGF 治療的最新進展顯著改善了濕型AMD的治療結果。白內障是一種眼睛水晶體變得混濁、視力下降的疾病。它通常與創傷、輻射暴露和某些遺傳因素導致的衰老有關。症狀包括視力模糊、看不清楚強光和顏色褪色。白內障的主要治療方法是透過手術摘除渾濁的晶狀體並用人工水晶體取代。科技的進步使白內障手術變得非常有效並提高了生活品質。

青光眼是一組損害視神經的眼科疾病，視神經對良好視力很重要，通常是由於異常高的眼壓引起的。它是 60 歲以上人群失明的主要原因之一。有開放性青光眼和隅角閉鎖性青光眼。透過定期眼科檢查及早發現很重要，因為症狀可能會在不知不覺中發展，直到出現嚴重的視力喪失。治療選擇包括眼藥水、雷射治療和手術以降低眼壓並防止視神經進一步受損。眼部發炎疾病，例如葡萄膜炎、鞏膜炎和眼部瘢痕性類天皰瘡，涉及眼睛各部位的發炎。這些疾病可能是由自體免疫疾病、感染疾病或接觸毒素引起的，如果不及時治療，可能會導致視力喪失等嚴重併發症。症狀包括發紅、疼痛、視力模糊和對光敏感。治療重點是根據根本原因和嚴重程度，使用皮質類固醇、免疫抑制劑和生物製藥來減輕發炎。近視、遠視、散光和老花眼等屈光不正是眼球形狀阻止眼睛正確彎曲光線，導致視力模糊的疾病。這些是影響世界各地所有年齡層最常見的眼科疾病。現代矯正方法包括眼鏡和隱形眼鏡以及LASIK和 PRK 等先進外科手術。屈光矯正手術的技術發展不斷提高安全性、有效性和病患滿意度。

最終使用者：醫院提供各種服務的貢獻不斷增加，從基本的眼科評估到複雜的手術干預

眼保健服務提供者包括多種營業單位，包括私人診所、社區健康中心和專業視力保健提供者。這些營業單位處於實施創新眼保健服務的最前沿，從常規眼科檢查到各種眼科疾病的高級診斷篩檢和治療方法。隨著預防性護理和早期檢測的興起，醫療保健服務提供者擴大採用人工智慧等最尖端科技進行視網膜影像分析。

醫院是眼科市場的重要組成部分，提供從基本眼科評估到複雜手術介入的各種服務。這些機構通常設有專門的眼科部門，配備最先進的設備來治療急性和慢性眼科疾病。醫院對於緊急管理、外科手術和需要多學科治療的治療至關重要。透過將先進的診斷和治療技術與管理複雜病例的專業知識相結合，醫院對於滿足全面的眼科護理需求至關重要。專門從事眼科的醫療機構是推動創新和教育的核心。這些機構提供臨床服務，並透過研究和發展為眼科知識的進步做出重大貢獻。我們提供專門的培訓和獎學金計劃，幫助下一代眼科醫生做好應對不斷變化的眼科護理挑戰的技能。醫療保健組織經常與產業合作夥伴合作進行臨床試驗並加速將研究成果轉化為臨床實踐。以眼科為重點的研究機構致力於發現眼科疾病病理學的新見解，開發創新的診斷工具，並確定新的治療策略。這些研究機構在提高我們對複雜眼科疾病的認知以及探索預防和治療方法發揮著重要作用。這些組織經常與學術界、醫療保健提供者和產業的相關人員合作，推廣多學科方法來解決眼部健康領域最緊迫的挑戰。

區域洞察

世界各地（包括美國、加拿大、中國、印度、德國等）的眼科護理和診斷服務正在改善眼科護理設施的普及，並擴大知名製造商創新設備和治療的可用性。由於年輕人生活方式的改變和忙碌的工作文化，智慧型手機、筆記型電腦、平板電腦和其他類似設備的使用增加，在新興經濟體和已開發經濟體中，屈光不良的負擔正在增加。此外，來自中國、印尼、日本和韓國等多個國家的製造商不斷生產獨特的眼鏡，以補充亞太地區的人口，並顯著塑造亞太地區的眼科市場空間。此外，隨著醫療機構和成熟市場參與者的研究活動的迅速增加和巨大的技術進步，以及人工智慧等尖端技術的整合，用於治療和矯正視力障礙的眼科產品將出現在各個領域。年的經濟使用量預計會增加。

FPNV定位矩陣

FPNV定位矩陣對於評估眼科市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對眼科市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，以獲得市場競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.眼科市場的市場規模和預測是多少？

2.眼科市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.眼科市場的技術趨勢和法規結構是什麼？

4.眼科市場主要廠商的市場佔有率是多少？

5.進入眼科市場的合適形式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 眼科疾病率上升及公眾意識增強
      • 處方眼鏡和鏡片的採用率增加
      • 擁有設備齊全的醫療基礎設施和不斷增加的藥品核准數量
    • 抑制因素
      • 眼科治療費用高
    • 機會
      • 眼科護理的新研究活動和津貼
      • 透過眼科技術整合可實現高可用性
    • 任務
      • 眼科手術專家數量有限
  • 市場區隔分析
    • 疾病：因老齡化黃斑部病變的進展而導致中心視力喪失
    • 最終使用者：醫院提供從基本眼科檢查到複雜手術介入等各種服務的貢獻增加
  • 市場趨勢分析
    • 遠距遠端醫療的出現和整個美洲眼保健的擴展
    • 新興企業，由於亞太地區失明和視力障礙的普遍存在，眼科藥物的需求不斷成長。
    • 歐洲、中東和非洲眼科藥物的研究活動迅速增加，技術不斷進步
  • 俄羅斯和烏克蘭衝突的累積影響
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法規結構分析
  • 客戶客製化

第6章眼科市場：依疾病分類

  • 老齡化黃斑部病變
  • 白內障
  • 青光眼
  • 發炎疾病
  • 屈光不正

第7章眼科市場：依產品類型

  • 藥物
  • 裝置
  • 處方眼鏡和鏡片
  • 軟體

第8章眼科市場：依最終使用者分類

  • 醫療保健服務供應商
  • 醫院
  • 醫療機構
  • 調查機構

第9章 北美和南美眼科市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太眼科市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲眼科市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 市場佔有率分析（2023）
  • FPNV定位矩陣（2023）
  • 競爭情境分析
    • Alkeus 宣布獲得 1.5 億美元 B 輪資金籌措
    • HOYA Vision 推出 MiYOSMART 太陽鏡片預防兒童近視
    • Curative Biotechnology 申請眼藥水專利
    • Eyetelligence是一家基於人工智慧的眼科疾病檢測Start-Ups，從投資者籌集了1200萬美元
    • Eyenovia 宣布 FDA核准首款散瞳噴霧劑 Mydcombi，該噴霧劑也利用了該公司專有的 Optejet 設備平台
    • 安斯泰來同意以 59 億美元收購 Iveric Bio
    • 博士倫 (Bausch + Lomb) 宣佈在美國推出 StableVisc 黏性眼科黏性手術器械和 TotalVisc 黏彈系統
    • NIDEK推出非接觸式眼壓計NT-1/1e
    • 塞拉尼斯宣布與 Glaukos Corporation 就緩釋青光眼治療達成協議
    • Thea Open Innovation 和 Galimedix 宣布產品開發和商業化策略
    • Grifols 與 Selagine 簽署協議，開發用於治療乾眼症的免疫球蛋白眼藥水
    • Topcon Healthcare 與 OphtAI 宣佈在歐洲、中東和非洲地區建立合作夥伴關係
    • Eyenovia 與 Formosa 合作開發新型眼科治療藥物
    • Viatris 收購 Oyster Point Pharma 和 Famy Life Sciences 成立眼科護理部門

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-4348D129FA96

[189 Pages Report] The Ophthalmology Market size was estimated at USD 59.90 billion in 2023 and expected to reach USD 63.89 billion in 2024, at a CAGR 6.64% to reach USD 93.99 billion by 2030.

Ophthalmology includes the study of medicines & surgeries dealing with the diagnosing and treating of eye disorders. Over the last few years, many significant developments in ophthalmology have been observed for cataract, refractive, and glaucoma surgeries. An increase in the well-equipped healthcare infrastructure and drug approvals strongly contribute to the market. Moreover, the rising prevalence of eye disorders and growing awareness among the worldwide population are driving the market growth. Furthermore, the high cost of ophthalmologic treatments due to the increasing prices of ophthalmologic treatment devices and technological advances may limit the market growth. Emerging research and development activities of ophthalmology treatments are supported by huge investments, prospering the market. Additionally, ongoing technological advancement and integration of artificial intelligence for early eye disease detection create lucrative market opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 59.90 billion
Estimated Year [2024] USD 63.89 billion
Forecast Year [2030] USD 93.99 billion
CAGR (%) 6.64%

Diseases: proliferation of age-related macular degeneration disease resulting in progressive loss of central vision

Age-related macular degeneration (AMD) is the most occurring condition primarily affecting older adults, leading to a progressive loss of central vision. This condition is categorized into dry (non-neovascular) and wet (neovascular) forms. The dry form is characterized by the accumulation of drusen in the macula, while the wet form involves neovascularization, causing rapid vision loss. Risk factors include age, genetics, smoking, and lifestyle. Recent advancements in anti-VEGF therapy have significantly improved treatment outcomes for wet AMD. A cataract represents clouding of the eye's natural lens, resulting in decrease in vision quality. It is most commonly related to aging resulting from trauma, radiation exposure, and certain genetic factors. Symptoms include blurred vision, difficulty with bright lights, and faded colors. The most primary treatment for cataracts is surgical removal of the clouded lens and replaced by an artificial lens implant. With technological advances, cataract surgery has become highly effective and offers improved quality of life.

Glaucoma represents a group of eye conditions that damage the optic nerves, crucial for good vision, often due to abnormally high pressure in the eye. It is one of the main causes of blindness for people over the age of 60. Types include open-angle and angle-closure glaucoma. Early detection through regular eye exams is important as the condition can progress unnoticed until significant vision loss occurs. Treatment options include eye drops, laser treatment, & surgery to lower eye pressure, thus preventing further optic nerve damage. Inflammatory diseases of the eye including uveitis, scleritis, and ocular cicatricial pemphigoid, involve inflammation of various parts of the eye. These conditions can arise due to autoimmune disorders, infection, or exposure to toxins and can lead to severe complications if left untreated, including vision loss. Symptomatology includes redness, pain, blurred vision, and light sensitivity. Treatment focuses on controlling inflammation with corticosteroids, immunosuppressive agents, and biologics tailored according to the underlying cause and severity of the disease. Refractive disorders, including myopia (nearsightedness), hyperopia (farsightedness), astigmatism, and presbyopia, are conditions in which the shape of the eye enables it to bend light correctly, resulting in blurred vision. They are among the most common ocular conditions affecting people of all ages globally. Modern corrective measures range from eyeglasses and contact lenses to advanced surgical options, including LASIK and PRK. Developments in refractive surgery techniques continue to enhance safety, efficacy, and patient satisfaction.

End User: Increasing contribution of Hospitals providing various services ranging from basic ophthalmic evaluations to complex surgical interventions

Healthcare service providers in ophthalmology encompass a broad range of entities, including private clinics, community health centers, and specialized vision care providers. These entities are at the forefront of implementing innovative eye care services, from routine eye exams to advanced diagnostic screenings and treatment modalities for various eye conditions. With a growing preventive care and early detection, healthcare service providers are increasingly adopting cutting-edge technologies such as AI for retinal imaging analysis.

Hospitals constitute a significant segment of the ophthalmology market, providing various services ranging from basic ophthalmic evaluations to complex surgical interventions. These institutions often house specialized ophthalmology departments with state-of-the-art facilities to manage acute and chronic eye conditions. Hospitals are crucial in managing emergencies, surgical procedures, and treatments requiring multidisciplinary care. The integration of advanced diagnostic and therapeutic technologies, alongside expertise in managing complicated cases, renders hospitals indispensable in addressing comprehensive eye health needs. Medical institutes specializing in ophthalmology are central to driving innovation and education. These institutes provide clinical services and contribute significantly to the advancement of ophthalmic knowledge through research and development. They offer specialized training and fellowship programs, preparing the next generation of ophthalmologists with the skills to address evolving eye health challenges. Medical institutes often collaborate with industry partners to conduct clinical trials, facilitating the translation of research findings into clinical practice. Research organizations dedicated to ophthalmology focus on uncovering new insights into the pathophysiology of eye diseases, developing innovative diagnostic tools, and identifying novel therapeutic strategies. Their work is instrumental in broadening our understanding of complex eye conditions and in the quest for preventative measures and cures. These organizations often collaborate with academia, healthcare providers, and industry stakeholders, driving interdisciplinary approaches to tackle the most pressing challenges in eye health.

Regional Insights

The utilization of ophthalmology treatment and diagnostics worldwide, including in the U.S., Canada, China, India, Germany, and others, is evolving rapidly with improving accessibility to ophthalmology care facilities and the growing availability of innovative devices and treatments offered by prominent manufacturers. The increasing utilization of smartphones, laptops, tablets, and other similar devices with changing lifestyles and busy work cultures among the younger population has increased the burden of refractive disorders in developing and developed economies. Furthermore, manufacturers from several countries, including China, Indonesia, Japan, and South Korea, are consistently producing unique eyeglasses that complement the regional population, significantly shaping the ophthalmology market space in the Asia-Pacific region. Moreover, with surging research activities and tremendous technological advancements undertaken by medical institutes and well-established market players, and integration of advanced technologies such as artificial intelligence is expected to increase the use of ophthalmologic products to treat and correct vision impairment across economies in the coming years.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Ophthalmology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Ophthalmology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmology Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Alcon Inc., Alkeus Pharmaceuticals, Inc., Apotex Inc., Bausch + Lomb Corporation, C.H. Boehringer Sohn AG & Co. KG, Carl Zeiss AG, ClearSight, CooperVision, Inc., Duopharma Consumer Healthcare Sdn Bhd, Essex Bio-Technology Limited, EssilorLuxottica S.A., Eyenovia, Inc., F. Hoffmann-La Roche AG, GenSight Biologics S.A., Geri-Care Pharmaceuticals Corp., Glaukos Corporation, Halma PLC, Harrow Health, Inc., Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services Inc., Kubota Pharmaceutical Holdings Co., Ltd., Lumenis Be Ltd., Nidek Co., Ltd., Novartis AG, OCuSOFT, Inc., Oxurion NV, Pfizer, Inc., PharmOptima LLC, Santen Pharmaceutical Co., Ltd., SEED Co., Ltd., Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Topcon Corporation, Unimed Pharma, Spols r.o., and Visioncare Optolab Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Ophthalmology Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Diseases
    • Age-Related Macular Degeneration
    • Cataract
    • Glaucoma
    • Inflammatory Diseases
    • Refractive Disorders
  • Product Type
    • Drugs
      • Allergic Conjunctivitis & Inflammation Drugs
      • Dry Eye Drugs
      • Glaucoma Drugs
      • Retinal Disorder Drugs
    • Equipment
      • Diagnostic Devices
      • Surgical Devices
        • Intraocular Lenses
        • Ophthalmic Lasers
    • Prescription Glasses & Lens
    • Software
  • End User
    • Healthcare Service Providers
    • Hospitals
    • Medical Institutes
    • Research Organizations
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Ophthalmology Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Ophthalmology Market?

3. What are the technology trends and regulatory frameworks in the Ophthalmology Market?

4. What is the market share of the leading vendors in the Ophthalmology Market?

5. Which modes and strategic moves are suitable for entering the Ophthalmology Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of eye disorders and growing awareness among the population
      • 5.1.1.2. Increasing adoption of prescription glasses and lenses
      • 5.1.1.3. Presence of well-equipped healthcare infrastructure and increasing number of drugs approvals
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of ophthalmologic treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging research activities of ophthalmology treatments and availability of grants
      • 5.1.3.2. High usage potential owing to the technological integrations in Ophthalmology
    • 5.1.4. Challenges
      • 5.1.4.1. Limited skilled professionals for ophthalmic procedures
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Diseases: proliferation of age-related macular degeneration disease resulting in progressive loss of central vision
    • 5.2.2. End User: Increasing contribution of Hospitals providing various services ranging from basic ophthalmic evaluations to complex surgical interventions
  • 5.3. Market Trend Analysis
    • 5.3.1. Emergence of telehealth and expansion of ophthalmology care across Americas
    • 5.3.2. Start-ups focusing on developing ophthalmology drugs with increasing need due to prevalence of blindness & vision impairment in Asia-Pacific
    • 5.3.3. Surging research activities and continuous technological advancements in ophthalmology therapeutics in EMEA
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Ophthalmology Market, by Diseases

  • 6.1. Introduction
  • 6.2. Age-Related Macular Degeneration
  • 6.3. Cataract
  • 6.4. Glaucoma
  • 6.5. Inflammatory Diseases
  • 6.6. Refractive Disorders

7. Ophthalmology Market, by Product Type

  • 7.1. Introduction
  • 7.2. Drugs
  • 7.3. Equipment
  • 7.4. Prescription Glasses & Lens
  • 7.5. Software

8. Ophthalmology Market, by End User

  • 8.1. Introduction
  • 8.2. Healthcare Service Providers
  • 8.3. Hospitals
  • 8.4. Medical Institutes
  • 8.5. Research Organizations

9. Americas Ophthalmology Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Ophthalmology Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Ophthalmology Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Alkeus Announces USD 150 million Series B Financing,
    • 12.3.2. HOYA Vision launches MiYOSMART Sun lenses to protect against myopia in children
    • 12.3.3. Curative Biotechnology files patent on ophthalmic formulation
    • 12.3.4. AI-based eye disease detection startup, Eyetelligence raises USD 12 million USD from investors
    • 12.3.5. Eyenovia Announces Fda Approval Of Mydcombi, The First Ophthalmic Spray For Mydriasis, Which Also Leverages The Company's Proprietary Optejet Device Platform
    • 12.3.6. Astellas reaches agreement to acquire Iveric Bio for USD 5.9 billion
    • 12.3.7. Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic System
    • 12.3.8. NIDEK launches the NT-1/1e Non Contact Tonometer
    • 12.3.9. Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment
    • 12.3.10. Thea Open Innovation and Galimedix announce strategic to develop and commercialize products
    • 12.3.11. Grifols enters agreement with Selagine to develop immunoglobulin eye drops to treat dry eye disease
    • 12.3.12. Topcon Healthcare and OphtAI Announce their Partnership in EMEA
    • 12.3.13. Eyenovia and Formosa partner for new ophthalmic therapeutics
    • 12.3.14. Viatris Forms Eye Care Unit from Acquisitions of Oyster Point Pharma and Famy Life Sciences

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. OPHTHALMOLOGY MARKET RESEARCH PROCESS
  • FIGURE 2. OPHTHALMOLOGY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. OPHTHALMOLOGY MARKET DYNAMICS
  • FIGURE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. OPHTHALMOLOGY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. OPHTHALMOLOGY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OPHTHALMOLOGY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL OPHTHALMOLOGY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY CATARACT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY REFRACTIVE DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS & INFLAMMATION DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DRY EYE DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY GLAUCOMA DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RETINAL DISORDER DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY OPHTHALMIC LASERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY PRESCRIPTION GLASSES & LENS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HEALTHCARE SERVICE PROVIDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY MEDICAL INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL OPHTHALMOLOGY MARKET SIZE, BY RESEARCH ORGANIZATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES OPHTHALMOLOGY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA OPHTHALMOLOGY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 309. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 310. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 321. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 322. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 333. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 334. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 343. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 344. FINLAND OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 345. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 346. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 349. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 350. FRANCE OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 351. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 352. FRANCE OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 353. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 354. FRANCE OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 355. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 356. FRANCE OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 357. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 358. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 359. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 360. GERMANY OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 361. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 362. GERMANY OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 363. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
  • TABLE 364. GERMANY OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
  • TABLE 365. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2018-2023 (USD MILLION)
  • TABLE 366. GERMANY OPHTHALMOLOGY MARKET SIZE, BY SURGICAL DEVICES, 2024-2030 (USD MILLION)
  • TABLE 367. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 368. GERMANY OPHTHALMOLOGY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 369. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2018-2023 (USD MILLION)
  • TABLE 370. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DISEASES, 2024-2030 (USD MILLION)
  • TABLE 371. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2023 (USD MILLION)
  • TABLE 372. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024-2030 (USD MILLION)
  • TABLE 373. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2018-2023 (USD MILLION)
  • TABLE 374. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY DRUGS, 2024-2030 (USD MILLION)
  • TABLE 375. ISRAEL OPHTHALMOLOGY MARKET SIZE, BY EQUIPMENT, 2018-20